| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.48B | 6.22B | 5.96B | 5.43B | 5.16B | 4.82B |
| Gross Profit | 1.51B | 1.24B | 652.90M | 716.30M | 1.04B | 1.02B |
| EBITDA | 830.80M | 573.40M | 81.50M | 191.00M | 572.20M | 500.10M |
| Net Income | 631.90M | 426.00M | 35.30M | 116.00M | 422.80M | 358.70M |
Balance Sheet | ||||||
| Total Assets | 16.77B | 15.27B | 14.61B | 14.00B | 14.25B | 13.44B |
| Cash, Cash Equivalents and Short-Term Investments | 915.70M | 2.02B | 316.10M | 305.00M | 230.90M | 7.58B |
| Total Debt | 1.28B | 784.10M | 783.20M | 782.40M | 781.60M | 780.80M |
| Total Liabilities | 13.35B | 12.43B | 12.15B | 11.66B | 11.11B | 10.24B |
| Stockholders Equity | 3.43B | 2.84B | 2.47B | 2.33B | 3.14B | 3.20B |
Cash Flow | ||||||
| Free Cash Flow | 1.00B | 796.20M | 349.80M | 704.50M | 815.70M | 692.70M |
| Operating Cash Flow | 1.01B | 806.40M | 361.70M | 722.30M | 823.70M | 707.60M |
| Investing Cash Flow | -792.90M | -541.50M | -228.50M | -507.60M | -460.20M | -608.80M |
| Financing Cash Flow | 270.00M | -145.50M | -122.10M | -140.60M | -253.20M | -193.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $5.52B | 15.76 | 19.49% | 4.05% | 3.72% | -16.23% | |
77 Outperform | $6.16B | 10.01 | 20.02% | 1.97% | 5.26% | 72.46% | |
77 Outperform | $5.10B | 13.01 | 12.22% | 1.85% | 10.98% | 74.87% | |
70 Neutral | $7.88B | 8.34 | 16.27% | 1.80% | 6.37% | 68.32% | |
69 Neutral | $4.97B | 11.30 | 21.47% | 1.34% | 6.18% | -21.28% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
52 Neutral | $2.33B | 10.38 | 9.03% | 3.15% | 4.51% | -8.29% |
On December 16, 2025, Hanover Insurance Group announced the redemption of its outstanding 4.500% Notes due 2026, originally issued in 2016. The redemption, scheduled for January 15, 2026, involves a total principal amount of $375 million, marking a significant financial maneuver for the company.
The most recent analyst rating on (THG) stock is a Hold with a $200.00 price target. To see the full list of analyst forecasts on Hanover Insurance stock, see the THG Stock Forecast page.